Voting Rights and Shares Capital Update of Nanobiotix

On September 22, 2026, Nanobiotix shared its latest figures related to voting rights and share capital. The biotechnology firm, publicly traded on both Euronext Paris and Nasdaq, reported a total of 50,941,528 shares outstanding as of August 31, 2026. This corresponds to 54,701,246 theoretical voting rights and 54,679,128 exercisable voting rights.

This update plays a crucial role in maintaining transparency for stakeholders, ensuring they have accurate insights into the company's governance structure. The details are governed in accordance with the French Commercial Code and regulations set by the French Financial Markets Authority, which mandate regular disclosures on these metrics.